| Description | Obinutuzumab (Obinutuzumab/afutuzumab) GA101) is a glycoengineered Type II CD20 monoclonal antibody in development for non-Hodgkin lymphoma. |
| Synonyms | 奥滨尤妥珠单抗, Obinutuzumab/afutuzumab |
| molecular weight | 150 kDa |
| CAS | 949142-50-1 |
| Storage | store at low temperature | store at -20°C | Shipping with blue ice. |
| References | 1. Herter S, et al. Preclinical activity of the type II CD20 antibody GA101 (obinutuzumab) compared with rituximab and ofatumumab in vitro and in xenograft models. Mol Cancer Ther. 2013 Oct;12(10):2031-42. |